IRVINE, Calif.–(BUSINESS WIRE)–Baylx, Inc. (Baylx), a clinical-stage stem cell biopharmaceutical company focused on developing living stem cell products to address unmet medical needs, announced that the U.S. Food and Drug Administration (FDA) has cl… […]
IRVINE, Calif., Sept. 30, 2020 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services is a presenting sponsor and exhibitor at the Outsourcing in Clinical Trials USA Virtual Experience even… […]
DUARTE, Calif.–(BUSINESS WIRE)– #CityofHope–Debbie C. Thurmond, Ph.D., has been named the new director of City of Hope’s Diabetes & Metabolism Research Institute. […]
Pfizer has engineered a wide-ranging China pact with CStone, with an initial $200 million investment and a license to the late-stage PD-L1 drug to get things started.
The US giant now claims 9.90% of CStone’s shares on the Hong Kong stock exchange, rig… […]
WESTLAKE VILLAGE, Calif., Sept. 29, 2020 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological d… […]
LOS ANGELES–(BUSINESS WIRE)–AltaSea at the Port of Los Angeles will honor two ocean exploration pioneers, Dr. Dawn Wright and Dr. Robert Ballard, during their inaugural The Blue Hour, a spectacular drive-in experience focusing on LA as the global cap… […]
SANTA ANA, Calif.–(BUSINESS WIRE)–FUJIFILM Irvine Scientific, Inc., today announced that it has become the exclusive, worldwide distributor of cellnest® […]
SAN DIEGO & LOS ANGELES–(BUSINESS WIRE)– #California–Biocom, the association representing the life science industry of California, today announced the appointment of Stephanie Hsieh as the organization’s executive director for its Los Angeles of… […]
LOS ANGELES–(BUSINESS WIRE)–Lyre’s Non-Alcoholic Spirit Co., the world’s most awarded line of non-alcoholic spirits and a key player in the emerging segment, has secured a total of $11.5 million (USD) in growth capital at the close of seed round fund… […]
Valerie Odegard
→ Accompanying the news that they just scored an $85 million Series C round, Laura Shawver-led Silverback Therapeutics has promoted two execs, with Valerie Odegard adding president to her CSO duties and Naomi Hunder moving to CMO. A Nov… […]
Copyright © 2021 Biotech Networks, LLC
